The Cypriot Competition Authority receives notification for an acquisition of a pharmaceutical company by a Luxembourg-based investment firm (Astrong Fund VIII / Corden Pharma)

Notification of a concentration concerning the acquisition by Astrong Fund VIII, SCSp of the share capital of Corden Pharma Holding S.E. and Corden Pharma US Holdings, Inc.* The Service of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Cypriot Competition Authority, The Cypriot Competition Authority receives notification for an acquisition of a pharmaceutical company by a Luxembourg-based investment firm (Astrong Fund VIII / Corden Pharma), 1 June 2022, e-Competitions June 2022 - II, Art. N° 106943

Visites 322

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues